TF was graded as unfavorable if the ocular signs did not meet WHO criteria of positive TF with 5 or more follicles of greater than 0. 5 mm8. == Nucleic Acid Amplification Testing == Eye swabs were collected for PCR analyses ofC. by the 12 months 2020 are based on the SAFE strategy: surgical treatment for treatment of trichiasis, mass drug supervision ofantibiotics, and promotion offacial cleanliness andenvironmental improvement. Because elimination efforts proceed, defining programmatic endpoints becomes a priority. We have recently begun examining the power of serological tests intended for post-endemic surveillance of trachoma elimination programs2. Antibody responses to theCtantigens pgp3 and CT694 show high sensitivity and specificity forCtinfection2. A large percentage of children living in trachoma-endemic areas have detectable antibody responses but exhibit no clinical signs and lack bacterial nucleic acidity in the conjunctiva, suggesting that these responses are indicators of historical rather than active infection2. No seroreversion was observed in seropositive individuals examined six months after drug treatment, although statistically significant decreases in antibody levels to pgp3 and CT694 were observed in more youthful age groups3. Post-endemic testing has shown very low seropositivity in young children in the absence of infection4(Westet al., submitted). Program end-points are currently set at <5% TF in 19 year-olds, operating under the assumption that low enough levels of ocular trachoma transmission will not result in downstream blindness. Since MDA will not uniformly result in zero transmission in districts, serosurveillance will only be useful to programs if there is a clear understanding of how seroprevalence relates to currently used indicators of trachoma. To this end, we evaluated age seroprevalence in areas described as hyperendemic, mesoendemic, or hypoendemic intended for trachoma based on TF and rates of ocular contamination, and estimated the basic reproduction number () for each scenario. == Methods == == Study Populace == Studies were conducted in the Kongwa District of Tanzania as part of two separate studies in collaboration with the Kongwa Trachoma Project. The first MPT0E028 is an ongoing study to evaluate the impact of alternative models of community-wide treatment with azithromycin and to compare nucleic acidity amplification test methods5, 6, 7(hyperendemic community). The second is a study to evaluate the health impact of an integrated NTD program on non-targeted diseases (mesoendemic and hypoendemic communities). Children 16 years of age were recruited from a single hyperendemic community and children 19 years of age were recruited from eight villages each to comprise the mesoendemic and hypoendemic areas. Clinical examinations for TF were performed by experienced graders, and dried blood spots (DBS) and conjunctival eye swabs for PCR were MPT0E028 collected. == Ethics Statement == Parents or guardians provided written informed consent for children participating in the study. Children over 7 provided verbal assent. The study was approved by The Institutional Review Boards from the Tanzanian National Institute intended for Medical Research (Dar es Salaam, TZ), Centers intended for Disease Control and Prevention (Atlanta, GA) for both studies and the Johns Hopkins University School of Medicine (Baltimore, MD) intended for the first study (hyperendemic community) only. The study was carried out in accordance with the approved guidelines. == Grading of Ocular Trachoma == Clinical exams, using the WHO simplified grading scheme8, were performed on children aged 1 to 9 years from nine villages in Kongwa District by an experienced trachoma grader. TF was graded as unfavorable if the ocular signs did not meet WHO criteria of positive TF with 5 or more follicles MPT0E028 of greater than 0. 5 mm8. == Nucleic Acid Amplification Testing == Eye swabs were collected for PCR analyses ofC. trachomatisfrom all children, with careful attention to avoid field contamination. Swabs from the hyperendemic community were sent to the International Chlamydia Research Laboratory at Johns Hopkins University IFNW1 and tested intended for the presence of chlamydial DNA using Amplicor CT/NG (Roche, Basel, Switzerland) because described3, 6. According to the manufacturers directions, the Amplicor test was positive if the optical density read at 450 nM was> 0. 8, negative if the signal.

TF was graded as unfavorable if the ocular signs did not meet WHO criteria of positive TF with 5 or more follicles of greater than 0